By the Numbers: Allulose Class-Action Lawsuits
Wave of complaints challenge sugar-free claims.
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
Wave of complaints challenge sugar-free claims.
Fall sale leaves much to be desired.
Looking to add a scare factor to your Halloween costume? Know the risks.
TINA.org found that movie ads in Life Together violated platform policy.
Why these products could lead to a Halloween horror story.